|
A novel mouse model of rhabdomyosarcoma |
Vanderbilt University Medical Center |
I Care I Cure |
|
Identification and validation of new therapeutic targets in pediatric leukemia through an aneuploidy-based synthetic lethality screen |
Dana-Farber Cancer Institute |
I Care I Cure |
|
Selective inhibition of nuclear export as a novel therapeutic strategy in AML |
Dana-Farber Cancer Institute |
I Care I Cure |
|
Development of An Innovative Treatment Strategy for Neuroblastoma and Other Pediatric Tumors: A Novel Phospholipid Ester Analogue and its Multifunctional Cancer-targeting Nanoconstruct |
University of Wisconsin - Madison |
I Care I Cure |
|
Development of Targeted Therapies in High Risk Childhood Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia |
I Care I Cure |
|
Pediatric Developmental Therapeutics Center of Excellence at UCSF |
University of California San Francisco |
I Care I Cure |
|
Development of a Childhood Leukemia Translational Research Program |
Dana-Farber Cancer Institute |
I Care I Cure |
|
Phase I and II Clinical Research Program Infrastructure Award - Brenda Weigel, MD/MSc (2011) |
University of Minnesota |
Northwestern Mutual Foundation |
|
Targeting polycomb-mediated epigenetic silencing in T cell acute lymphoblastic leukemia |
Vanderbilt University Medical Center |
I Care I Cure |
|
Mechanisms of Oncogenic Transformation by TLX1/HOX11 |
University of Michigan |
I Care I Cure |
